Article Text

Download PDFPDF
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * See glossary.

  • Information provided by author.

  • Sources of funding: Sanofi-Synthelabo and Bristol-Myers Squibb.

  • For correspondence: Dr H Parving, Steno Diabetes Center, Gentofte, Denmark. hhp{at}